Publications
April 19, 2022
New Guide for Friends/Family: How to Ask If They’re Getting Addicted
Worried about someone’s drinking or drug use, but not sure what to say? This new guide in Psyche, written by ADAI research scientist K. Michelle Peavy, PhD, describes a counseling approach that can help: Community Reinforcement Approach and Family Counseling (CRAFT). Many people who want to talk with someone about their drinking or drug use…
April 6, 2022
ADAI Report: Methadone: An Old Medication with Untapped Potential
Learn about methadone, a medication long used in the U.S. as a treatment for opioid use disorder, in this new report, Methadone: An Old Medication with Untapped Potential, by ADAI research scientists K. Michelle Peavy, PhD and Caleb Banta-Green, PhD, MPH, MSW. The report explains what methadone is and how it works, as well as…
March 30, 2022
New ADAI Research: Cannabis Store Location and Advertising Influences Use by Oregon Youth
This new paper in Health and Place, led by Caislin Firth and in collaboration with the Oregon Health Authority, looks at the impact of retail cannabis store location and exposure to cannabis advertising on youth cannabis use. The project was partially funded by the National Institutes of Drug Abuse awarded to co-author Julia Dilley and the Horowitz Foundation…
March 8, 2022
Results from the 2021 WA State Syringe Service Program Health Survey
The biennial WA State Syringe Service Program Health Survey is the state’s primary source of data on the substance use patterns, health behaviors, and health care needs of people who use drugs and utilize syringe service programs (SSPs). The University of Washington’s Addictions, Drug & Alcohol Institute (ADAI) conducts the survey in collaboration with Public…
February 16, 2022
New from ADAI/FADU: Prenatal Alcohol Exposure and Mental Health at Midlife
The effects of prenatal alcohol exposure (PAE) have been studied a lot, with a particular focus on physical birth defects and neurocognitive development. Much less studied has been an association between PAE and mental health disorders, especially for adults with both PAE and fetal alcohol spectrum disorders (FASD). Though some research has found a connection…
January 31, 2022
New from ADAI: Distributing Safer Smoking Supplies Can Help Reduce Health Risks of Opioid/Stimulant Use
In Washington State and across the country, fentanyl has quickly become a major opioid in the illicit drug supply. Fentanyl, especially in pill form, is most often smoked rather than injected. Similarly, methamphetamine is most typically smoked and its use and fatal overdoses have increased rapidly in recent years. Harm reduction programs, including syringe services programs (SSPs), do a great job…
January 26, 2022
New from ADAI: Cannabis Industry Marketing Violations in WA, 2014-2019
UPDATE (December 2023): This paper was named the 9th most-cited paper of 2022 in the Journal of Studies on Alcohol & Drugs! There’s a conflict between prevention and profit when it comes to marketing by the cannabis industry in Washington State, say ADAI researchers Beatriz Carlini, PhD, Sharon Garrett, MPH, MA, and Caislin Firth, PhD,…
December 16, 2021
New ADAI Report: Housing Program Staff Want More Training to Address Substance Use
To learn more about the needs of housing professionals who work with people who use substances, ADAI staff Alison Newman, MPH and Susan Kingston conducted an anonymous, online survey in September 2021. The objectives of this survey were to: identify successes and challenges, determine how knowledgeable and comfortable staff feel in working with substance use,…
December 8, 2021
New ADAI Report: Dramatic Increases in Opioid Overdose Deaths Due to Fentanyl Among Young People in WA
Use of illicitly manufactured fentanyl has had an outsized impact on overdose deaths in Washington State, according to a new report from ADAI/UW Psychiatry research scientists Caleb Banta-Green and Jason Williams. Fentanyl use and overdose deaths appear to mostly affect these populations: young adults inexperienced with opioid use young adults with rapid onset opioid use…
November 30, 2021
New Report: WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution
The Washington State Project to Prevent Prescription Drug/Opioid Overdose (WA-PDO) was a five-year project supported by the WA State Health Care Authority/Division of Behavioral Health and Recovery with funds from the Substance Abuse and Mental Health Services Administration. The goal of the project was to prevent opioid overdose in WA State by building a statewide…
Previous page Next page
